Sign in
4

Changes in Ownership

RxSight, Inc. Filed Acc 0000950170-24-128218

See remarks sold 7,975 shares at an average $45.61 ($363,752)

  • See remarks acquired 7,975 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Goldshleger Ilya See remarks 2024-11-15 Option exercise 10b5-1 +4,875 $15.08 $73,515 47,121 D: show line 1 in the form
Goldshleger Ilya See remarks 2024-11-15 Sale 10b5-1 −4,875 $46.00 $224,250 42,246 D: show line 2 in the form
Goldshleger Ilya See remarks 2024-11-18 Option exercise 10b5-1 +3,100 $15.08 $46,748 45,346 D: show line 3 in the form
Goldshleger Ilya See remarks 2024-11-18 Sale 10b5-1 −3,067 $45.00 $138,015 42,279 D: show line 4 in the form
Goldshleger Ilya See remarks 2024-11-18 Sale 10b5-1 −33 $45.07 $1,487 42,246 D: show line 5 in the form
Open-market sales · 7,975 sh · avg $45.61 · $363,752

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Goldshleger Ilya See remarks 2024-11-15 Option exercise · Stock Option (right to buy) 10b5-1 −4,875 53,182 D: show line 6 in the form
Goldshleger Ilya See remarks 2024-11-18 Option exercise · Stock Option (right to buy) 10b5-1 −3,100 50,082 D: show line 7 in the form
Loading xslF345X05/ownership.xml…